Ligand validation:5S81

XJV: imidazolidin-2-one

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5S81_XJV_B_507	56%	14%	0.129	0.901	2.02	1.79	3	2	0	0	100%	0.58
5S81_XJV_B_506	52%	9%	0.12	0.876	2.31	2.06	2	2	0	0	100%	0.58
5S81_XJV_A_510	50%	17%	0.184	0.938	1.87	1.64	3	2	0	0	100%	0.56
5S81_XJV_B_508	40%	8%	0.126	0.835	2.36	2.14	2	2	0	0	100%	1
5S81_XJV_A_511	24%	7%	0.189	0.82	2.42	2.28	3	2	0	0	100%	0.48
5S81_XJV_B_505	13%	7%	0.161	0.705	2.41	2.25	3	2	3	0	100%	0.5
7H4R_XJV_A_201	74%	93%	0.101	0.933	0.18	0.26	-	-	0	0	100%	0.54
7H8C_XJV_D_206	71%	92%	0.099	0.92	0.17	0.3	-	-	0	0	100%	0.68
7HIH_XJV_D_205	62%	93%	0.1	0.89	0.15	0.29	-	-	0	0	100%	0.64
7HII_XJV_D_206	60%	93%	0.108	0.893	0.13	0.29	-	-	0	0	100%	0.55
7HIJ_XJV_A_208	56%	93%	0.111	0.881	0.15	0.28	-	-	0	0	100%	0.65

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.